Tag: Cardiovacular
IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack
IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular therapy. IPS HEART was the first company to exclusively focus on induced pluripotent stem cells...
